Stocks LESL Financial statements
Financial statementsLeslie's, Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Leslie's, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 928 | 1,112 | 1,343 | 1,562 | 1,451 | 1,330 | 1,242 |
| Cost of revenue | 548 | 652 | 748 | 888 | 903 | 853 | 802 |
| Gross profit | 380 | 461 | 595 | 674 | 548 | 477 | 440 |
| Selling, general and administrative | 258 | 314 | 386 | 435 | 446 | 420 | 426 |
| Operating income | 122 | 146 | 209 | 239 | 102 | 57.1 | -170 |
| Interest expense | 98.6 | 84.1 | 34.4 | 30.2 | 65.4 | 70.4 | 62.9 |
| Other non-operating income | -7.45 | -1.09 | -2.38 | -0.4 | 0 | 0 | |
| Pre-tax income | 15.6 | 61.2 | 163 | 208 | 36.7 | -13.3 | -233 |
| Income tax | 14.9 | 2.63 | 36.5 | 49.1 | 9.5 | 10.1 | 4.2 |
| Net income | 0.7 | 58.6 | 127 | 159 | 27.2 | -23.4 | -237 |
| EBITDA | 149 | 175 | 236 | 267 | 132 | 86.3 | -141 |
| EPS, basic | 0.00 | 7.28 | 13.37 | 16.91 | 2.96 | -2.53 | -25.57 |
| EPS, diluted | 0.00 | 7.28 | 13.18 | 16.72 | 2.95 | -2.53 | -25.57 |
| Shares, basic (weighted) | 7.96 | 7.96 | 9.43 | 9.37 | 9.19 | 9.23 | 9.27 |
| Shares, diluted (weighted) | 7.96 | 7.96 | 9.66 | 9.47 | 9.23 | 9.23 | 9.27 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 157 | 343 | 112 | 55.4 | 109 | 64.3 | |
| Receivables | 31.5 | 38.9 | 45.3 | 29.4 | 45.5 | 23.2 | |
| Inventory | 149 | 199 | 362 | 312 | 234 | 208 | |
| Other current assets | 4.06 | 8.88 | 12.4 | 5.92 | 9.44 | 10.9 | |
| Total current assets | 360 | 602 | 542 | 420 | 422 | 329 | |
| Property, plant and equipment | 66.4 | 70.3 | 78.1 | 90.3 | 98.4 | 92.5 | |
| Lease right-of-use assets | 178 | 212 | 236 | 251 | 270 | 253 | |
| Goodwill | 89.7 | 93.3 | 101 | 174 | 181 | 181 | 0 |
| Intangible assets | 27.9 | 27.9 | 40.2 | 38.2 | 34.4 | 30.7 | |
| Other non-current assets | 14.4 | 25.1 | 37.7 | 46 | 39.7 | 36.4 | |
| Total assets | 746 | 1,042 | 1,110 | 1,034 | 1,050 | 741 | |
| Accounts payable | 92.4 | 101 | 156 | 58.6 | 67.6 | 51.9 | |
| Accrued liabilities | 101 | 90.6 | 107 | 82.4 | |||
| Short-term debt | 8.34 | 8.1 | 8.1 | 8.1 | 8.1 | 0 | |
| Total current liabilities | 258 | 310 | 348 | 226 | 247 | 209 | |
| Long-term debt | 1,180 | 786 | 780 | 773 | 769 | 752 | |
| Lease liabilities | 130 | 160 | 180 | 193 | 209 | 185 | |
| Other non-current liabilities | 5.46 | 3.92 | 0.07 | 3.47 | 2.42 | 2.99 | |
| Total liabilities | 1,573 | 1,260 | 1,308 | 1,196 | 1,227 | 1,149 | |
| Total debt | 1,201 | 806 | 798 | 790 | 784 | 757 | |
| Paid-in capital | -278 | 205 | 89.9 | 99.3 | 107 | 113 | |
| Retained earnings | -549 | -422 | -288 | -261 | -284 | -521 | |
| Shareholders' equity | -887 | -827 | -218 | -198 | -161 | -177 | -408 |
| Total equity | -887 | -827 | -218 | -198 | -161 | -177 | -408 |
| Total liabilities and equity | 746 | 1,042 | 1,110 | 1,034 | 1,050 | 741 | |
| Shares outstanding | 7.96 | 9.65 | 9.33 | 184 | 9.25 | 9.29 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 0.7 | 58.6 | 127 | 159 | 27.2 | -23.4 | -237 |
| Depreciation and amortization | 27.9 | 28.9 | 26.6 | 27.8 | 29.8 | 29.2 | 29.3 |
| Stock-based compensation | 2.13 | 1.79 | 24.2 | 11.3 | 11.7 | 8.59 | 6.2 |
| Deferred income tax | -0.75 | -7.82 | 2.85 | 2.47 | -6.33 | 3.43 | 4.46 |
| Change in inventory | -3.8 | 1.76 | -47.8 | -143 | 54.3 | 85.9 | 26.3 |
| Change in payables | 23.8 | 38.1 | 35.8 | 55.5 | -97.9 | 1.89 | -15.7 |
| Cash from operations | 57.8 | 102 | 169 | 66.6 | 6.47 | 107 | 8.82 |
| Capital expenditures | -27.4 | -20.6 | -28.9 | -31.7 | -38.6 | -47.2 | -25.5 |
| Acquisitions | -9.62 | -6.19 | -8.87 | -108 | -15.5 | 0 | 0 |
| Cash from investing | -37 | -26.8 | -35.4 | -139 | -52.5 | -47.2 | -25.4 |
| Debt issued | 0 | 0.91 | 0 | 0 | |||
| Debt repaid | -6.26 | -10.4 | -396 | -8.1 | -8.1 | -6.08 | -27 |
| Share buybacks | 0 | 0 | -152 | 0 | 0 | ||
| Dividends paid | -1.24 | ||||||
| Cash from financing | -7.5 | -10.4 | 53.8 | -159 | -10.8 | -7.22 | -27.6 |
| Net change in cash | 13.3 | 64.9 | 188 | -231 | -56.9 | 53.1 | -44.2 |
| Free cash flow | 30.4 | 81.5 | 140 | 34.9 | -32.1 | 60.2 | -16.7 |
| Interest paid | 90.5 | 88.7 | 36.4 | 32.6 | 63.1 | 63.2 | 65.4 |
| Income taxes paid | 12.9 | 15.3 | 28.6 | 41.1 | 22.6 | 10.9 | 3.39 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 33.7% | Gross profit / revenue. |
| Operating margin | -16.5% | Operating income / revenue. |
| EBITDA margin | -13.9% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -21.4% | Pre-tax income / revenue. |
| Net margin | -21.2% | Net income / revenue. |
| FCF margin | -0.5% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 0.9% | Cash from operations / revenue. |
| Return on assets (ROA) | -34.7% | Net income / average total assets. |
| Return on invested capital (ROIC) | -62.1% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 34.0% | Selling, general and administrative expense / revenue. |
| Stock-based pay / revenue | 0.3% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 1.4% | Capital expenditures / revenue. |
| D&A / revenue | 2.7% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -6.6% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -7.4% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 2.2% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -7.8% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -13.3% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -0.9% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating income growth, 1y | -397.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| EBITDA growth, 1y | -262.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| Operating cash flow growth, 1y | -91.8% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -49.0% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -38.7% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | -127.7% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Total assets growth, 1y | -29.4% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -12.6% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -0.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 0.4% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | -0.7% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 3.1% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.35x | Current assets / current liabilities. |
| Quick ratio | 0.30x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.18x | (Cash + short-term investments) / current liabilities. |
| Debt / assets | 108.9% | Total debt / total assets. |
| Liabilities / assets | 168.2% | Total liabilities / total assets. |
| Net debt | $740.7M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Interest coverage | -3.39x | Operating income / interest expense. |
| Working capital | $91.0M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 3.9% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | -$520.9M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 1.63x | Revenue / average total assets. |
| Fixed asset turnover | 15.6x | Revenue / average property, plant and equipment. |
| Inventory turnover | 3.35x | Cost of revenue / average inventory. |
| Days inventory | 109 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 36.7x | Revenue / average receivables. |
| Days sales outstanding | 10 days | 365 x average receivables / revenue. |
| Days payables | 52 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 67 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 159.7% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$26.25 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $123.62 | Revenue / diluted weighted shares. |
| FCF per share | -$0.66 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $1.11 | Cash from operations / diluted weighted shares. |
| Book value per share | -$52.61 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | -$55.62 | Tangible book value / shares outstanding. |
| Cash per share | $4.90 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $2.7M | Share price x shares outstanding. |
| Enterprise value | $743.5M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.00x | Market cap / revenue. |
| P/OCF | 0.26x | Market cap / cash from operations, when positive. |
| EV/Sales | 0.63x | Enterprise value / revenue. |
| FCF yield | -232.0% | Free cash flow / market cap. |
| Earnings yield | -9,160.0% | Net income / market cap (the inverse of P/E). |
What was Leslie's, Inc.'s revenue in fiscal 2025?
Leslie's, Inc. reported revenue of $1.24B for fiscal 2025, 6.6% lower than the year before.
Was Leslie's, Inc. profitable in fiscal 2025?
No. It reported a net loss of $237.0M.
How much free cash flow did Leslie's, Inc. generate in fiscal 2025?
Cash from operations of $8.8M minus capital expenditures of $25.5M left free cash flow of -$16.7M.